Espié M - Search Results

1

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.

Pivot X, Romieu G, Debled M, Pierga JY, Kerbrat P, Bachelot T, Lortholary A, Espié M, Fumoleau P, Serin D, Jacquin JP, Jouannaud C, Rios M, Abadie-Lacourtoisie S, Venat-Bouvet L, Cany L, Catala S, Khayat D, Gambotti L, Pauporté I, Faure-Mercier C, Paget-Bailly S, Henriques J, Grouin JM; PHARE trial investigators. Pivot X, et al. Among authors: espie m. Lancet. 2019 Jun 29;393(10191):2591-2598. doi: 10.1016/S0140-6736(19)30653-1. Epub 2019 Jun 6. Lancet. 2019. PMID: 31178155 Clinical Trial.

2

Hereditary epidermolytic palmoplantar keratoderma associated with breast and ovarian cancer in a large kindred.

Blanchet-Bardon C, Nazzaro V, Chevrant-Breton J, Espie M, Kerbrat P, Le Marec B. Blanchet-Bardon C, et al. Among authors: espie m. Br J Dermatol. 1987 Sep;117(3):363-70. doi: 10.1111/j.1365-2133.1987.tb04144.x. Br J Dermatol. 1987. PMID: 2960371

3

Dysgerminoma in a pure 45,X Turner syndrome: report of a case and review of the literature.

Pierga JY, Giacchetti S, Vilain E, Extra JM, Brice P, Espie M, Maragi JA, Fellous M, Marty M. Pierga JY, et al. Among authors: espie m. Gynecol Oncol. 1994 Dec;55(3 Pt 1):459-64. doi: 10.1006/gyno.1994.1323. Gynecol Oncol. 1994. PMID: 7835789 Review.

4

Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method.

Dieras V, Extra JM, Bellissant E, Espie M, Morvan F, Pierga JY, Mignot L, Tresca P, Marty M. Dieras V, et al. Among authors: espie m. J Clin Oncol. 1996 Dec;14(12):3097-104. doi: 10.1200/JCO.1996.14.12.3097. J Clin Oncol. 1996. PMID: 8955654 Clinical Trial.

5

[Treatment of breast cancer].

Espié M. Espié M. Presse Med. 1998 Sep 12;27(26):1332-5. Presse Med. 1998. PMID: 9779053 Review. French.

6

Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.

Ardavanis A, Extra JM, Espié M, Cuvier C, Marty M. Ardavanis A, et al. Among authors: espie m. In Vivo. 1998 Sep-Oct;12(5):559-62. In Vivo. 1998. PMID: 9827368 Clinical Trial.

7

Optimizing chemotherapy for patients with advanced breast cancer.

Marty M, Espie M, Cottu PH, Cuvier C, Lerebours F. Marty M, et al. Among authors: espie m. Oncology. 1999 Jul;57 Suppl 1:21-6. doi: 10.1159/000055265. Oncology. 1999. PMID: 10436413 Review.

8

Single-agent gemcitabine is active in previously treated metastatic breast cancer.

Spielmann M, Llombart-Cussac A, Kalla S, Espié M, Namer M, Ferrero JM, Diéras V, Fumoleau P, Cuvier C, Perrocheau G, Ponzio A, Kayitalire L, Pouillart P. Spielmann M, et al. Among authors: espie m. Oncology. 2001;60(4):303-7. doi: 10.1159/000058524. Oncology. 2001. PMID: 11408796 Clinical Trial.

9

Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy.

Bertheau P, Plassa F, Espié M, Turpin E, de Roquancourt A, Marty M, Lerebours F, Beuzard Y, Janin A, de Thé H. Bertheau P, et al. Among authors: espie m. Lancet. 2002 Sep 14;360(9336):852-4. doi: 10.1016/S0140-6736(02)09969-5. Lancet. 2002. PMID: 12243922

10

Gemcitabine and epirubicin in patients with metastatic breast cancer: a phase I/II study.

Campone M, Fumoleau P, Viens P, Diéras V, Pujade-Lauraine E, Serin D, Petit T, Espié M, Kayitalire L, Bozec L, Pouillart P. Campone M, et al. Among authors: espie m. Breast. 2006 Oct;15(5):601-9. doi: 10.1016/j.breast.2005.11.010. Breast. 2006. PMID: 17045160 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

228 results

Search Page